Literature DB >> 3931153

Mechanisms of the initial treatment phenomenon to diazepam in the rat.

D J Mokler, R H Rech.   

Abstract

The initial treatment phenomenon (ITP) to diazepam was investigated using a conditioned suppression of drinking (CSD) paradigm. Female Sprague-Dawley rats were trained to a stable baseline of punished and unpunished responses in the CSD paradigm. In Experiment 1, a control group (1) received vehicle after the CSD session on each of seven drug test days, while group 2 was treated with 3.0 mg/kg diazepam IP after each of these sessions. On drug test days 8-12, diazepam was administered to both groups before the CSD session. Drug test days were separated by 2-3 days when the animals were untreated but performed in the CSD. Prior exposure to diazepam in group 2 after sessions 1-7 conditioned the animals so that a greater release in punished behavior was seen during sessions 8-12 than in the control group (1). In Experiment 2, one group (3) of rats was administered diazepam vehicle after the CSD session for 4 drug test days and another group (4) was injected with 5.6 mg/kg diazepam after the CSD session on these same days. On the next 4 drug test days both groups received diazepam before they performed in the CSD. An ITP was observed in both the control (3) and the drug-conditioned (4) group, although the ITP was less obvious in the conditioned group. After a 28-day period of CSD exposure without vehicle or drug treatments, 5.6 mg/kg diazepam was administered to both groups before the CSD session for an additional 8 drug test days.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931153     DOI: 10.1007/bf00431816

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Adaptive changes in behavior after repeated administration of various psychoactive drugs.

Authors:  R H Rech; H A Tilson; W J Marquis
Journal:  Adv Biochem Psychopharmacol       Date:  1975

Review 2.  Behavioral analysis of the effects and mechanisms of action of benzodiazepines.

Authors:  L Cook; J Sepinwall
Journal:  Adv Biochem Psychopharmacol       Date:  1975

Review 3.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

4.  Conflict behavior in the squirrel monkey: effects of chlordiazepoxide, diazepam and N-desmethyldiazepam.

Authors:  J Sepinwall; F S Grodsky; L Cook
Journal:  J Pharmacol Exp Ther       Date:  1978-01       Impact factor: 4.030

5.  A further note on studies of acquired behavioural tolerance to alcohol.

Authors:  C S Chen
Journal:  Psychopharmacologia       Date:  1972

6.  Management of the office patient with anxiety and depression.

Authors:  R S Warner
Journal:  Psychosomatics       Date:  1965 Sep-Oct       Impact factor: 2.386

7.  Increase of "antianxiety" activity and tolerance of behavioral depression during chronic administration of oxazepam.

Authors:  D L Margules; L Stein
Journal:  Psychopharmacologia       Date:  1968

Review 8.  Behavioural tolerance to amphetamine and other psychostimulants: the case for considering behavioural mechanisms.

Authors:  C Demellweek; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Comparison of anti-conflict drug effects in three experimental animal models of anxiety.

Authors:  C D Kilts; R L Commissaris; R H Rech
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Factors in ethanol tolerance.

Authors:  B Tabakoff; C L Melchior; P Hoffman
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  1 in total

1.  Effect of aging on anticonflict and CNS depressant activity of diazepam in rats.

Authors:  H L Komiskey; M A Buck; K L Mundinger; F K McSweeney; V A Farmer-Dougan; J D Dougan
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.